Integral Health Asset Management’s MacroGenics MGNX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-500,000
| Closed | -$7.36M | – | 89 |
|
2024
Q1 | $7.36M | Buy |
500,000
+50,000
| +11% | +$736K | 0.68% | 53 |
|
2023
Q4 | $4.33M | Buy |
+450,000
| New | +$4.33M | 0.59% | 56 |
|
2022
Q1 | – | Sell |
-130,000
| Closed | -$2.09M | – | 86 |
|
2021
Q4 | $2.09M | Sell |
130,000
-30,000
| -19% | -$482K | 0.58% | 50 |
|
2021
Q3 | $3.35M | Buy |
+160,000
| New | +$3.35M | 0.96% | 45 |
|
2021
Q2 | – | Sell |
-175,000
| Closed | -$5.57M | – | 84 |
|
2021
Q1 | $5.57M | Buy |
175,000
+85,000
| +94% | +$2.71M | 1.59% | 24 |
|
2020
Q4 | $2.06M | Hold |
90,000
| – | – | 0.61% | 45 |
|
2020
Q3 | $2.27M | Buy |
90,000
+20,000
| +29% | +$504K | 0.69% | 51 |
|
2020
Q2 | $1.95M | Buy |
+70,000
| New | +$1.95M | 0.59% | 51 |
|